An evidence-based review of silymarin’s potential to mitigate chemotherapy-induced liver injury, covering clinical trials in breast cancer and pediatric ALL, pr
Learn about the three primary flavonolignans in milk thistle seed extract, their chemical structures, and what research suggests about their roles in liver heal
Milk thistle’s silymarin has notoriously low bioavailability. Here’s the pharmacokinetic reason why, and what phospholipid, SMEDDS, and cocrystal formulas try t
Silymarin and silybin are often used interchangeably, but they aren’t the same thing. Here’s how the milk thistle flavonolignan complex relates to its most acti
Milk thistle and TUDCA support liver health through different mechanisms. Here’s an honest, evidence-based comparison of what each does and doesn’t do.
A clear, evidence-based look at milk thistle’s side effects, who should be cautious, and drug interactions to know before taking silymarin.
Emerging lab and animal research on silymarin for kidney protection, beyond its well-known role in liver support.
A side-by-side look at milk thistle (silymarin) and artichoke leaf extract (cynarin) for liver support, based on available clinical research.
What the clinical research actually shows about milk thistle’s timeline, dosing windows, and why liver markers respond at different speeds.
A practical, evidence-honest guide to choosing a milk thistle supplement: what silymarin standardization means, dosing ranges, and quality red flags.
How milk thistle (silymarin) affects CYP450 liver enzymes and P-glycoprotein, which medications are most likely affected, and what the evidence actually shows.
Does milk thistle (silymarin) lower cholesterol or triglycerides? A look at the human trial and meta-analysis evidence on lipid panels.